General patient characteristics. حسب Ekaterina A. Bryushkova (13360122)

الموضوعات:

Individual dynamics of blood parameters. حسب Ekaterina A. Bryushkova (13360122)

الموضوعات:

Baseline clinical characteristics of patients. حسب Ekaterina A. Bryushkova (13360122)

الموضوعات:

Changes in CRP and LDH levels over time. حسب Ekaterina A. Bryushkova (13360122)

الموضوعات:

Minimal dataset. حسب Ekaterina A. Bryushkova (13360122)

الموضوعات:

The outcome timepoints and the mortality level of patients. حسب Ekaterina A. Bryushkova (13360122)

الموضوعات:

Founder haplotype means and 1-SDs for the three QTL mapped in both panels of DSPR RILs. حسب Michael A. Najarro (831657)

Effects of LY5 are not mediated via STAT3 inhibition. حسب Peter Y. Yu (4281448)

TH588 effectively decreases cellular survival in heterogeneous neuroendocrine tumor cells. حسب Elke Tatjana Aristizabal Prada (833927)

The sialidase inhibitor Neu5Ac2en decreases growth of wt <i>C. canimorsus 5</i> in presence of macrophages. حسب Manuela Mally (348810)

Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism. حسب Bolin Liu (59887)

Transaldolase deficiency alters mitochondrial morphology and decreases <i>in vivo</i> mitochondrial respiration. حسب Christopher F. Bennett (3875731)

"…The bottom panel consists of a max intensity projection of five z-slices to emphasize mitochondrial content in these cells. …"

IgG and gestational age in neonatal intensive care unit (NICU). حسب Hiromi Yamaguchi (2396248)

الموضوعات:

Clinical outcome at 60 days based on SaFi, anakinra and a simplified SCOPE. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

A hypoglycaemic <i>milieu</i> decreases NCS viability in a dose-dependent manner. حسب Shiva Mansouri (2838086)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. حسب Franco A. Rossato (588513)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. حسب Franco A. Rossato (588513)

Resveratrol decreases CYP17A1 and CYP21A2 protein expression. حسب Nesa Marti (3851059)

"…<p>A. Gene expression profiling by qRT-PCR was performed for CYP17, CYP21 and their cofactor POR in H295R cells grown under normal conditions (GM), starvation conditions (SM), metformin (Met) (1mM) treatment and under resveratrol (RSV) (5<u>μM)</u> treatment. …"

BMP type I receptor antagonists decrease Smad 1/5/8 activity in H1299 cells. حسب Elaine Langenfeld (402034)

CD5-2 decreases established CCM lesions in the hindbrain of <i>Ccm2</i>^<i>ECKO</i> mice and lesions in the retina of <i>Ccm2</i>^<i>ECKO</i> mice. حسب Jia Li (160557)